Assessment of PD-L1 mRNA expression in gastrointestinal tumors and the response to immunotherapy
BackgroundProgrammed death ligand 1 (PD-L1) immunohistochemistry (IHC) has been proposed as a predictive biomarker to predict response to immunotherapy. Given the limitations of IHC test in PD-L1 detection, this study aimed to investigate the technical feasibility of using quantitative RT-PCR (qRT-P...
Main Authors: | Qingqing Qiu, Jieyi Li, Qiaofeng Chen, Xiaokai Zhao, Ru Zhou, Wenpeng Zhang, Ziying Gong, Daoyun Zhang, Mingliang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.926746/full |
Similar Items
-
Unraveling EGFR-TKI resistance in lung cancer with high PD-L1 or TMB in EGFR-sensitive mutations
by: Wuwu Ding, et al.
Published: (2024-01-01) -
BCG downregulates PD1 and PD-L1 expression in bladder cancer cells co-cultivated with peripheral blood mononuclear cells
by: Katia R. M. Leite, et al.
Published: (2022-10-01) -
Comparative Analysis of Inhibitory and Activating Immune Checkpoints PD-1, PD-L1, CD28, and CD86 in Non-Melanoma Skin Cancer
by: Linus Winter, et al.
Published: (2024-09-01) -
Transcriptomic Analysis Reveals Genes Associated with the Regulation of Peach Fruit Softening and Senescence during Storage
by: Shaolei Guo, et al.
Published: (2023-04-01) -
Evaluation of ALK, EGFR and PD-L1 Mutations in Pulmonary Carcinomas through Immunohistochemistry
by: Teona Bushati, et al.
Published: (2023-07-01)